Lilly announced that 3mL (300-unit) vials of Humalog (insulin lispro [recombinant]) and Humulin R U-100 (regular insulin [human, recombinant]) will be made available to hospitals in January 2010.

BD announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe designed for patients with diabetes taking Humulin R U-500 insulin (regular insulin [human, rDNA origin]; Eli Lilly).

Insulet To Develop New Version Of The OmniPod Insulin Pump For Use With Humulin R U-500 Concentrated Insulin For People With Type 2 Diabetes. Bedford, MA (Marketwired) - Insulet Corporation ...

Find patient medical information for Insulin Regular on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings Skip to main content Home ...

Einmalige Gelegenheit?: Eines der aufregendsten Junior-Goldexplorationsprojekte in Australien im Fokus! Anzeige. Indizes Kurs % News 24 h / 7 T Aufrufe 7 Tage; Aktien Kurs ...

Recombinant DNA, a lab technique developed in the early 1970s, allowed pharmaceutical manufacturers to genetically engineer bacteria to produce human insulin. This “recombinant insulin” first came on ...

Humulin R U-500 insulin vial has been available with no dedicated device for delivery since 1994. To administer the insulin, healthcare practitioners and patients had to make dose conversions to ...

Arecor Therapeutics plc(“Arecor” or “the Company”) AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN DEMONSTRATES SUPERIORITY IN PHASE I CLINICAL TRIAL IN OVERWEIGHT AND OBESE PEOPLE ...

Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States Tuesday, October 28, 2008 General News Advertisement ...

Insulet to Develop New Version of the OmniPod Insulin Pump for Use With Humulin R U-500 Concentrated Insulin for People With Type 2 Diabetes Marketwired Thu, May 2, 2013, 8:00 AM ...